GMT Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
GMT Capital's RXRX Position: Q3 2026 in Review
GMT Capital opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 4,856,167 shares worth $20.1M. The stake represents 0.95% of the portfolio and ranks #25 among its holdings.
350 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- GMT Capital held 4,856,167 shares of Recursion Pharmaceuticals worth $20.1M as of Q3 2026.
- Recursion Pharmaceuticals was a new GMT Capital position in Q3 2026.
- Recursion Pharmaceuticals made up 0.95% of GMT Capital's portfolio in Q3 2026, its #25 holding.
- 350 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on GMT Capital's 13F filing for Q3 2026, filed 16 Nov 2026.